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Expanding use of emergency endovascular repair
for ruptured abdominal aortic aneurysms: Disparities
in outcomes from a nationwide perspective
Kelly Lesperance, MD, Charles Andersen, MD, Niten Singh, MD, Benjamin Starnes, MD, and
Matthew J. Martin, MD, Tacoma, Wash
Background: Endovascular repair (EVAR) of abdominal aortic aneurysms (AAA) has become widely accepted in the
elective setting but remains controversial for emergency repair of ruptured aneurysms (rAAA). We sought to examine the
national trends in use and associated outcomes with EVAR.
Methods: The Nationwide Inpatient Sample (NIS) was used to analyze all admissions for rAAA from 2001 through 2004.
Nationwide temporal trends and demographics using weighted samples were evaluated. Focused univariate and
multivariate analyses comparing outcomes from open repair and EVAR were done for the years 2003 and 2004.
Results: There were 28,123 admissions for rAAA, with a stepwise decline in admissions from 2001 to 2004. Use of EVAR
increased significantly from 6% of all emergency repairs in 2001 to 11% in 2004 (P < .01). Mortality for EVAR declined
significantly from 43% to 29% (P < .01), but mortality with open repair showed no change (40% to 43%). From the 2003
to 2004 data set, 949 EVAR and 8982 open repairs were identified. Compared with open repair, the EVAR patients had
lower mortality (31% vs 42%), shorter hospital stay (6 vs 9 days), and were more likely to be discharged to home (59% vs
37%, all P < .01). The total hospital charges for EVAR and open repair were similar ($71,428 vs $74,520, P  .59).
Mortality for EVAR was significantly higher at nonteaching hospitals compared with teaching centers (55% vs 21%, P <
.01) and at nonteaching centers, even exceeding that of open repair (46%). Regression modeling confirmed the overall
benefits of EVAR as well as the worse outcomes at nonteaching facilities after adjusting for patient comorbidities, disease
severity, and hospital or system covariates.
Conclusions: Endovascular repair is being increasingly used in the emergency management of ruptured AAA, with steadily
decreasing mortality during the study period. Endovascular AAA repair is associated with improved mortality and
outcomes compared with open repair, but results in nonteaching centers are substantially worse than those in teaching
hospitals. ( J Vasc Surg 2008;47:1165-71.)Abdominal aortic aneurysm (AAA) formation is the
result of degenerative vascular disease and is associated with
high morbidity, mortality, and financial cost. Elective repair
of these aneurysms is usually well tolerated and associated
with low mortality and morbidity. These outcomes are
drastically different for patients presenting with an acutely
ruptured or rupturing aneurysm. Ruptured AAA (rAAA)
confers a significantly increased risk of adverse outcome and
death, and is responsible for 15,000 deaths annually,1
with an estimated 59% to 83% prehospital mortality and
30% to 80% mortality among those who survive to reach
medical care.2 The use of endovascular AAA repair (EVAR)
has increased drastically since the initial report in 1991 by
Parodi et al3 and has been followed by marked improve-
ments in endovascular techniques and equipment.
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doi:10.1016/j.jvs.2008.01.055Although a large amount of prospective controlled data
validate this technique for elective AAA repair,4,5 there is a
paucity of data available for the use of EVAR emergently in
the setting of rAAA.6 Several case reports and case series
have demonstrated acceptable outcomes with EVAR for
rAAA,7-10 but most are small, retrospective, and limited by
the lack of a valid control group. In addition, these may
represent a highly selective set of results from large-volume
expert centers and may not be truly representative of all
centers. The purpose of this study is to examine the demo-
graphic patterns and outcomes associated with the use of
EVAR for patients presenting with rAAA from a large
nationwide sample. Our study compares these factors with
those of patients with rAAA who were chosen for open
repair.
METHODS
Data for this study were obtained using the 2001
through 2004 Nationwide Inpatient Sample (NIS), a prod-
uct of the Health Care Utilization Project, Association for
Healthcare Research and Quality. Provided by the Depart-
ment of Health and Human Services, the NIS is the largest
inpatient, all-payer database in the United States (US), with
data on 8 million hospital stays per year. The stratified
sampling frame and discharge weights contained within the
NIS allow for the creation of accurate national estimates from
this approximate 20% sample of all nationwide discharges.
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pitals from 33 to 37 states were sampled by the NIS. States
excluded from each year group were not identical from year
to year. Discharge weights are created by the NIS to weight
each admission so that it is properly represented within the
data set to allow nationwide estimates to be obtained from
this 20% subsample. The weights are based on the various
demographic and hospital strata created by the NIS design.
All analyses performedwere weighted analyses. This admin-
istrative database contains information on both admission
and discharge diagnoses, patient demographics and comor-
bid conditions, procedures performed, complications, hos-
pital mortality, hospital charges, and discharge destination.
In addition, the NIS now contains multiple validated sever-
ity-adjustment measures to aid in group comparisons for
clinical research.11
The 2001 through 2004 NIS data set was queried for
all patients with a primary admission diagnosis of abdomi-
nal aortic aneurysm using International Classification of
Disease, Ninth Revision, Clinical Modification (ICD-9-
CM) codes. All patients with an ICD-9-CM code of 441.3
(AAA, ruptured) or 441.4 (AAA, not ruptured) who were
directly admitted to the hospital were included. Our anal-
ysis excluded patients who were transferred from outside
facilities.
Patients were then classified as undergoing either an open
AAA repair (open group) or an endovascular aneurysm repair
(EVAR group) by review of all available ICD-9-CM proce-
dure codes. All records with procedure codes for both open
repair and EVAR were assumed to be conversions from
EVAR to open repair and were grouped as EVAR using an
intention-to-treat design. Patients who did not survive to
undergo repair or who had no procedure code for a defin-
itive aneurysm repair were excluded.
All data fields were analyzed for completeness and
appropriate range of values. Continuous variables with
significant deviation from a normal distribution (ie, length
of stay) were log-adjusted before statistical analysis. This
data set was used to analyze temporal trends in the demo-
graphics, types of repair, and unadjusted outcomes during
the 4-year period. The two groups have inherent differ-
ences at baseline that confer selection bias. The univariate
comparisons are presented to describe and compare the
groups, not to attribute any causal relation to type of repair
or outcome.
For a more detailed analysis of this patient cohort and the
associated type of repair, the data from the 2003 and 2004
NIS data sets were combined. The years 2001 and 2002 were
excluded from the detailed analysis because they were consid-
ered to be early in the EVAR experience. The last 2 years of
our study period were chosen for in-depth query to include
only the most recently available data and outcomes in detail.
The primary axis of comparison was between the open
and EVAR groups. Patient and hospital demographics,
hospital charges, and outcomes were compared using un-
adjusted univariate analysis. A 2 analysis or Fischer exact
test was used for categoric variables, and a Mann-Whitney
U test or Student t test was used for continuous variables.Select variables were then entered into a standard multivar-
iate logistic regression model to identify any independent
factors associated with hospital mortality. Significant inter-
actions between independent variables in the model were
assessed using standard collinearity diagnostics, with a cut-
off tolerance of 0.10 or variance inflation factor10. No
significant collinearity interactions were identified in the
model.
An adjustment for individual patient disease severity
was included in this model, using the predicted mortality
score contained in the NIS derived from the proprietary
Disease Staging 5.21.3 system (Medstat, Ann Arbor,
Mich).12 The mortality score represents the predicted mor-
tality divided by the overall rate of in-hospital mortality (for
the NIS)  100. It is the best validated variable contained
in the data set for comparing the overall illness or disease
severity of patients or groups, incorporating baseline vari-
ables and all available diagnostic codes. An internal valida-
tion analysis of the mortality score was performed for our
specific data set and found to be strongly predictive of
mortality for the entire data set and for the subgroups of
open and EVAR. Results are presented as adjusted odds
ratios with 95% confidence intervals (CI), where appropri-
ate. Statistical significance for this study was set at  0.05.
This study was performed in accordance with the NIS Data
User Agreement and approval was obtained through the
local Institutional Review Board. All data adjustment and
analysis was performed using SPSS 12.0 software (SPSS
Inc, Chicago, Ill).
RESULTS
Trends from 2001 to 2004. The use of endovascular
repair for all AAA increased during our study period, from
17,775 performed in 2001 to 29,046 in 2004. During this
time, the number of patients presenting to US hospitals
with the diagnosis of rAAA decreased, from 7749 in 2001 to
6383 in 2004. Fig 1 shows the significant increase in the use of
EVAR for rAAA, from 6% of all repairs in 2001 to 11% of
repairs in 2004 (P  .01). Although the mortality for all
patients admitted with AAA was 2.9% to 3.9%, mortality
among all patients presenting with a ruptured aneurysm re-
Fig 1. Percentage of ruptured abdominal aortic aneurysms (rAAA)
that underwent endovascular repair.mained significantly higher, at about 50% (range, 49%-53%).
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patients with rAAA who underwent open repair or EVAR.
Although themortality for open repair has remained steady at
40% to 45% during the study period, the mortality associated
with EVAR has progressively declined, from 43% in 2000 to
29% in 2004 (P  .01). The interaction demonstrated be-
tween the year of surgery and type of surgery (open vs EVAR)
was also significant (P .01).
Detailed analysis of 2003 and 2004 data. All
records meeting our inclusion criteria from the 2003 and
2004 NIS data sets were included in the weighted study
sample. There were 9931 records identified and included
for analysis, of whom 8982 patients underwent open repair
and 949 underwent EVAR. The demographics and comor-
bidities of the two groups are reported in Table I. The two
groups were similar with respect to age, sex, and pre-
existing comorbid conditions, but patients undergoing
open repair had a significantly higher estimated mortality
score and underwent more secondary surgical procedures
than the EVAR group. The differences in the hospital
characteristics between the two groups were also signifi-
cant, with EVAR being performed more frequently in
teaching hospitals and in the Northeast and South geo-
graphic distributions.
Table II compares the unadjusted outcomes between
the two groups. The EVAR group had a significantly lower
mortality compared with the open repair group. In addi-
tion, EVAR was associated with shorter hospital stay and
less discharge disability requiring skilled nursing place-
ment. Of note, the median hospital charges between the
two group were not significantly different (Table II) at
$74,520 (interquartile range, $88,585) for open repair and
$71,428 (interquartile range, $66,749) for EVAR for
rAAA (P  .58). The number of rAAA performed at
nonteaching centers slightly decreased from 2408 in 2003
and 2195 in 2004, and a slight increase was seen at teaching
centers, 2405 and 2923, respectively. This difference was
statistically significant (P  .01). This sample represented
data from 450 hospitals, of which 288 were nonteaching
(64%) and 162 were teaching (36%). On further univariate
analysis, a significant difference in mortality was noted
Fig 2. Mortality rate of open (gray bars) vs endovascular (EVAR,
black bars) repair of ruptured abdominal aortic aneurysms
(rAAA).between patients with rAAA treated at nonteaching hospi-tals compared with teaching centers (Fig 3). The mortality
in both the open and EVAR groups was higher at non-
teaching centers compared with teaching hospitals. In ad-
dition, at nonteaching hospitals the EVAR associated mor-
tality (55%) was actually higher than that of open repair
(46%), which was the reverse of the pattern seen at teaching
centers (P  .001).
To further analyze factors associated with mortality and
adjust for patient and disease-related factors, all variables of
interest from the univariate analysis were entered into a
forward stepwise logistic regression model. This included
age, sex, race, presence of comorbid conditions, mortality
score, type of aortic repair, hospital location (region, hos-
pital type, urban/rural), and teaching status of hospital.
Table III lists the results of the multivariate regression.
Increased age, higher mortality score, and open repair were
all independent factors associated with hospital mortality.
Although hospital region or type were not significant fac-
tors, the hospital teaching status remained a strong inde-
pendent predictor as it was on univariate analysis. Adjusted
mortality for rAAA was increased at hospitals designated as
Table I. Demographics patients with ruptured
abdominal aortic aneurysm undergoing open vs
endovascular repair and hospital variables
Patient and hospital variables Open EVAR P
Patient, No. (%) 8982 (90) 949 (10)
Age, mean  SD years 73.1  8.9 73.9  9.5 .01
Sex, % .39
Female 22 24
Male 78 76
Race, % .004
Caucasian 61 66
Non-Caucasian 10 10
Missing 29 24
Surgical procedures, mean 
SD No. 5.3  3.0 4.9  2.6 .001
Mortality score, mean  SDa 2015  833 1813  840 .001
Known comorbid
conditions, %
Pulmonary disease 33 32 .838
Diabetes 10 11 .666
Hypertension 47 48 .714
Liver Disease 0.8 2 .001
Peripheral vascular disease 18 18 .761
Renal failure 7 8 .249
Region of hospital, % .001
Northeast 19 28
Midwest 27 21
South 35 42
West 19 9
Location of hospital, % .89
Urban 90 90
Rural 10 10
Hospital teaching status, % .001
Teaching 52 72
Nonteaching 48 28
EVAR, Endovascular aneurysm repair.
aMortality score from Disease Staging 5.21.3 system (Medstat, Ann Arbor,
Mich), score log adjusted for statistical comparison.“nonteaching” centers in the NIS, with an odds ratio of 1.3
th of s
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but did not reach statistical significance as independent
predictors of mortality.
DISCUSSION
Our data demonstrated a decrease number of patients
presenting with rAAA nationwide. Increased use of AAA
screening is likely responsible for this decline. For the
general public, the US Preventative Services Task Force
recommends a one-time screening ultrasound for all men
between 65 and 75 years who smoke or have previously
smoked. This represents 70% of all men in this age group.2
One prospective study on the effect of AAA screening on
the incidence of rAAA cites a 49% reduction during a 7-year
Table II. Outcome measures for open vs endovascular an
Outcome measure Op
Patient, No (%) 8982 (9
LOS, median (IRQ) days 9 (
Total hospital charges, median (IRQ) $ 74,520 (
Discharge status, %
To home 22
To skilled care 42
In-hospital mortality, % 42
EVAR, Endovascular aneurysm repair; IQR, interquartile range; LOS, leng
Fig 3. Mortality rate of open (gray bars) vs endovascular repair
(EVAR, black bars) of ruptured abdominal aortic aneurysms in
teaching and nonteaching hospitals.
Table III. Independent variables associated with hospital
mortality on multivariate logistic regression
Variable Adjusted OR 95% CI P
Age 1.02 1.01-1.03 0.001
Female sex 1.10 0.99-1.23 0.06
Caucasian race 0.88 0.76-1.01 0.08
Open repair 1.47 1.26-1.71 0.05
Hospital location 1.07 0.93-1.23 0.34
Nonteaching hospital 1.31 1.20-1.43 0.001
Mortality scorea 1.97 1.76-2.20 0.001
CI, Confidence interval; OR, odds ratio.
aMortality score from Disease Staging 5.21.3 system (Medstat, Ann Arbor,
Mich), score log adjusted for statistical comparison.period (95% CI, 3%-74%).13Endovascular repair of AAA has increased significantly
nationwide since its introduction in the early 1990s. It is
considered the procedure of choice for those with severe
medical comorbidities that amplify perioperative risks, such
as myocardial infarction and multisystem organ failure. The
option of repair under local anesthesia provided by EVAR
potentially compounds this benefit.6,7 A recently pub-
lished, large retrospective study of high-risk patients receiv-
ing care at the Veterans Affairs Administration who under-
went EVAR for elective AAA repair cites a significantly
lower 30-day and 1-year mortality in these patients.14
These benefits of EVAR are also demonstrated in pa-
tients presenting with rAAA. On univariate analysis, our
data collected from the NIS reflects a significant decrease in
mortality after EVAR for rAAA, shorter hospital stay, and
increased likelihood of returning home after hospital ad-
mission. Patients who underwent EVAR required fewer
secondary procedures while hospitalized for rAAA, most
common of which were tracheostomy placement and ex-
ploratory laparotomy. Although differences in outcomes
are significantly associated with patients selected for each
repair type, we cannot causally attribute them to the pro-
cedure due to selection bias, because the groups are clearly
not randomly assigned or equally selected.
Our data reflect an increasing role for EVAR in rAAA
repair, and this trend is mirrored in emerging litera-
ture.3,15,16 A recent review conducted by the Cochrane
collaboration recognizes that although no completed ran-
domized controlled trials currently exist, evidence from
both prospective and retrospective reviews demonstrates
the feasibility of the use of EVAR for rAAA. They show that
this technique may reduce blood loss, length of stay in the
intensive care unit, and death in selected patients.6
Most studies in the literature are small, single-institution
retrospective reviews that lack information on patient selec-
tion that would offer more insight into its widespread
applicability. Factors that are proposed to influence choice
of operative repair are aneurysmal characteristics and pa-
tient hemodynamic instability. The percentage of patients
presenting with rAAA with favorable anatomy suitable for
stent graft placement has been reported with variability in
the literature, between 46% and 81%.3,6 This percentage is
likely to increase as advances continue in stent graft tech-
m repair
EVAR P
949 (10)
6 (10) .001
85) $ 71,428 ($66,749) .58
41 .001
20 .001
31% .001
tay.eurys
en
0)
15)
$88,5
%nology and manufacturing.
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lar repair, including relative “ease” of repair conferred by its
geometry, introduces the potential for selection bias into
our data set. Although many variables were included in our
multivariate analysis attempting to correct the imbalance
between the two groups, anatomic information was not
available within the NIS. Anatomic characteristics are not
an isolated consideration, because a patient’s hemodynamic
stability influences the likelihood of obtaining a preopera-
tive computed tomography (CT) scan vs going straight to
the operating room. Many retrospective reviews of EVAR
use for rAAA have excluded the population deemed too
unstable to undergo preoperative CT imaging15,16 for ac-
curate measurement of aneurysm diameter and length.
Others include these patients, using techniques such as an
aortic occlusion balloon to gain rapid proximal vascular
control9,17,18 or stent grafts that fit a variety of common
aneurysm sizes.9,10,17
On analysis of mortality rates after EVAR for rAAA at
teaching and nonteaching hospitals, our data reflect para-
doxic outcomes. Although a significantly favorable mortal-
ity benefit is seen with EVAR for rAAA at teaching hospi-
tals, this procedure carries a higher risk of in-hospital death
than open repair when performed at a nonteaching facility.
This trend was confirmed on multivariate analysis, repre-
senting “adjusted” analytic results. Hospital patient vol-
ume, availability, and accessibility of resources, surgeon
experience, including on-call staff, with endovascular tech-
nique and comfort level of performing an EVAR likely
contribute to this discrepancy. Other factors, such as a
vascular resident available to set up the operating room,
measure the AAA, and obtain the endograft, also likely play
a role in the difference.
One large retrospective review examining factors asso-
ciated with morbidity and mortality after repair of rAAA
found that high-volume surgeons with subspecialty train-
ing in vascular or cardiothoracic surgery conferred a signif-
icant survival benefit.19 As with anything in a procedure-
based specialty, volume increases proficiency.
Some analyses of outcomes for patients undergoing
repair of rAAA in teaching or university centers vs non-
teaching or community centers have cited no significant
differences in mortality,8,20 but so far, these studies have
been small, have excluded EVAR, or compared data from a
single institution.21 A large prospective trial would be
useful in delineating qualities of both hospital types that
contribute to positive and adverse outcomes.
Prehospital care, mobilization of resources, and hospi-
tal staff expertise that accompany facilities designated as
regional trauma centers have a demonstratedmorbidity and
mortality benefit in the treatment of rAAA.22 Proficiency in
expediting care in many types of emergency situations is
part of the phenomenon referred to as the “halo effect” that
these facilities confer.22 Hospital staff, including nurses,
technicians and vascular surgeons with knowledge of the
preoperative preparation, necessary equipment, and expe-
rience deploying endoluminal grafts are essential. Institu-
tional capacity to offer EVAR for rAAA also requires accessto multiple stent grafts of different sizes or grafts that can fit
several aortic diameters.3 After establishing and practicing a
protocol for treatment of rAAA with EVAR, one large
teaching center demonstrated through a prospective anal-
ysis of 40 consecutive patients a mortality rate of only
18%.17 The study included both stable and unstable pa-
tients, with 25% of patients presenting with a systolic blood
pressure of 80 mm Hg.
Results of a recent Canadian study of 126 patients
substantiated the mortality benefit of protocol establish-
ment for the use of EVAR for rAAA. A prospective analysis
of 30-day mortality after its introduction demonstrated a
significant reduction in mortality for patients undergoing
EVAR for rAAA from 30% before the protocol to 17.9%
after the protocol was instituted (odds ratio, 0.385; 95%
CI, 0.141-0.981; P  .046).23 Interestingly, this study
showed a trend toward improved mortality for hemody-
namically unstable patients who underwent EVAR rather
than open repair.23
Our study does have several significant limitations that
should be noted. It is a retrospective review of a large
prospectively collected administrative database, which can
be affected by missing data fields and inaccurate or mis-
coded entries. As is common with these types of databases,
it is hard to “personalize” all the relevant clinical variables
that a physician would consider when deciding on a course
of treatment, such as physiologic status of the patient and
availability of local resources. The NIS does now contain
several proprietary “disease severity” variables that can be
used to adjust for severity of illness, but these are based on
available diagnostic and procedure codes that may vary by
hospital or region.
The time frame of this study is during the relative
infancy of the application of EVAR for rAAA, and may
not reflect the current or future outcomes associated
with this approach as new devices and modifications have
been made. Similarly, the differences noted between
teaching and nonteaching centers may reflect these cen-
ters being at different points on the learning curve for
this technology. It may also be the result of differences in
patient disease, selection, or timing of intervention that
could not be appreciated from the available data. This
finding would require further detailed and prospective
analysis to confirm.
Hospital and surgeon-specific procedure volumes likely
influence patient selection for type of rAAA repair. We
believe that including this entirely separate and complex
variable could introduce further bias and confounding. We
chose to analyze only the clearly stated and defined hospital
variables contained in the NIS, such as hospital region and
hospital teaching status. Without detailed information on
procedure volume, individual surgeon volume, and infra-
structure, we are hesitant to undertake this additional anal-
ysis, which may be more likely misleading than additive.
This topic would be an excellent subject for a completely
separate future analysis.
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Dr John A. Schwartz (Medford, Ore). Pesident Ballard,
members, and guests. The authors have presented their review of
the trends in admissions for and the management of ruptured
abdominal aortic aneurysm (rAAA) over a 4-year period. They
have performed a detailed analysis of the results of surgical inter-
vention for rAAA in nearly 10,000 patients over the 2-year period
of 2003 and 2004. These data were obtained from the Nationwide
Inpatient Sample. This provides nationwide estimates from a 20%
sample of discharge data from hospitals in 37 states.
The detailed analysis of the data set revealed that 90% of
repairs for rAAA were open and 10% endovascular. Endovascular
aneurysm repair (EVAR) of rAAA resulted in an 11% decrease in
overall mortality compared with open repair and was associated
with similar numbers of secondary procedures, cost, length of stay
and a higher probability of discharge to home rather than a skilled
care facility. Seventy-two percent of EVARs were performed at
teaching hospitals compared with only 28% in community non-
teaching centers. Ninety percent of the centers were categorized as
urban. In the manuscript, the region of the Western Vascular
Society apparently contributed a very low percentage of EVARs toThe authors concluded that EVAR is being increasingly uti-
lized in the emergency management of ruptured AAA with a
steadily declining mortality. EVAR is associated with improved
mortality and outcomes compared with open repair, but results in
nonteaching hospitals were substantially worse than those ob-
tained in teaching centers.
This paper is important. It adds to the growing literature
confirming the feasibility and efficacy of EVAR for ruptured AAA.
The concept of endovascular damage control to arrest hemorrhage
and serve as either an adequate treatment or a bridge to definitive
surgical or secondary endovascular intervention is very appealing.
However, the results of the present study, like most of the litera-
ture regarding comparisons of open and endovascular repair for
rAAA, are difficult to interpret because often patients with symp-
tomatic aneurysms—but not ruptured—were included and the
preprocedural hemodynamics of these patients are not considered
in relationship to the outcome.
Moreover, the interpretation of results for like patients is
limited by selection bias and the anatomic restrictions of current
endovascular devices. One cannot account for self-selection of
more robust patients who tolerate transport to tertiary hospitals or
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confirmed the benefit of EVAR as well as the worst outcome at
nonteaching facilities after adjusting for both patient comorbidity
and disease severity. However, they do not describe which variables
from this administrative database provided this information. The
manuscript did not elaborate on the proprietary mortality score,
nor did it explain what that number really means in any relative
clinical perspective. My guess is that if I were a patient, I would not
want to have a score of 2000.
The main limitation of the study, as the authors point out in
the manuscript, resides in its foundation—an administrative data-
base. The accuracy of the data depends on the precision of the
coding that clerical personnel enter into the database and is subject
to errors due to nonmedical or lay interpretation. There are nu-
merous pertinent coding issues that are not accounted for, such as
pararenal aneurysms, complex iliac anatomy, aneurysm neck
length, and angulation, all of which enter into the selection of the
type of intervention and its eventual outcome.
The use of EVAR for rAAA is clearly expanding; however, due
to the nature of the data available for this analysis, there is no way
to account for the apparent discrepancies in outcome. The authors
enumerate their speculations in their discussion of the results in the
manuscript. For many reasons, a retrospective analysis of results
between the presented groups is much less of a direct comparison
and more a simple reporting of results. Like many studies, this
paper raises more questions in my mind than it answers. I have
several questions for the authors; one more than violates the
Zierler rule.
One, you noted geographic differences in utilization of EVAR
for ruptured AAA. Why do you think that percentage is so low in
the West? Are there any regions underrepresented in the Nation-
wide Inpatient Sample, or more specifically which 13 states are not
included?
Two, since you have reported the outcome of intervention for
ruptured AAA by teaching and nonteaching hospitals, does that
allow you to assess the effect of individual institutional volume on
the outcome?
Three, in your analysis you assume that patients coded for
both open and endovascular procedures were conversions and
grouped as EVARs. In light of the significant increase of morbidity
and mortality with conversions of elective EVAR to open repair,
how many patients did this represent and what was the mortality
rate in this subgroup?
Four, do you have any information from the database regard-
ing the nature of the secondary procedures in the detailed analysis?
A mean of approximately five procedures per patient seems quite
high. Did any of these involve the treatment of secondary rupture
from endoleak?
Finally, I would like to congratulate the authors on this study
and fine presentation, and thank the Western Vascular Society for
the opportunity to discuss this paper.
Dr Kelly Lesperance. Thank you, Dr Schwartz, for reviewing
our manuscript and providing those insightful comments. The first
question posed by Dr Schwartz addresses the discrepancy in use of
endovascular repair seen in different regions of the country. These
differences were not found to be predictive of type of repair
performed on multivariate analysis. During our study period,between 986 and 1004 hospitals from 33 to 37 states were sampled
by the NIS. States excluded from each year group were not
identical from year to year.
The second question addresses whether individual surgeon
performance in endovascular AAA repair may contribute to the
difference in outcomes between teaching and nonteaching hospi-
tals. Although this question cannot be answered from our data-
base, a separate analysis of our data examining outcomes associated
with relative hospital volume in AAA repair may shed some light.
Increasing numbers of elective AAA repairs were associated with
better outcomes with use of EVAR for ruptured AAA compared to
those which used this technique less frequently in the elective
setting.
Third, our analysis did not include an in-depth review of the
patients that were coded with both open and endovascular proce-
dures. Instead, they were grouped into the EVAR group, for
intention-to-treat purposes of our analysis. We agree that these
patients likely had worse outcomes and a review of these patients
may be beneficial. However, our inclusion of these patients in the
EVAR group would then be expected to worsen the outcomes in
this group, and strengthen our overall conclusions.
The fourth question addresses the nature of secondary
procedures necessary during hospitalization. Procedures most
commonly coded for in these patients include imaging such as
computed tomography scan, need for mechanical ventilation,
tracheostomy, and exploratory laparotomy. While we may infer
that patients who received EVAR whose charts also included an
exploratory laparotomy may have suffered a complication of
their repair, it would be difficult to tell this definitively from the
NIS database.
In discussion of some concerns about this study presented by
Dr Schwartz, I will address the topic of selection bias, an inevitable
factor in choosing a repair type for patients with this emergency
condition. Selection bias, in this case, reflects the inherent limita-
tions to the use of EVAR for rAAA. The limitations include the
ability to obtain preoperative imaging, which is somewhat depen-
dent on the patient’s presenting hemodynamic status. Availability
of resources such as a collection of stent grafts, operating room
resources such as an imaging table, knowledgeable support staff
and a vascular surgeon comfortable with endovascular techniques
all play a role.
Mortality score is a proprietary scoring system used by the
Nationwide Inpatient Sample to help adjust for disease severity
between groups. This score takes into account comorbid condi-
tions, diagnoses, and procedures performed. Although we do not
have all the information for every patient that is computed into the
score, it does provide a slight buffer to this selection bias and shows
that patients who did undergo open repair tended to be the more
unstable or sicker patients. Our analysis did validate that this score
strongly correlated with patient outcome regardless of the type of
repair.
Certainly we recognize that any database that relies on ICD-9
coding is prone to errors, such as those mentioned byDr Schwartz.
Assuming that these coding errors are randomly distributed, the
large size of our data set should compensate for this coding error.Thank you for the opportunity to present our research.
